Journal article
Recent advances in tuberculosis treatment: Towards shorter, safer, and more effective therapies
Journal of clinical tuberculosis and other mycobacterial diseases, Vol.42, 100582
2026
DOI: 10.1016/j.jctube.2026.100582
PMCID: PMC12854055
PMID: 41624601
Abstract
Tuberculosis (TB), caused by Mycobacterium tuberculosis, is the leading infectious cause of death globally. Although effective treatments are available, treatment length, drug toxicity, and the emergence of drug-resistant strains have challenged TB control efforts. Current clinical trials are focused on developing shorter, safer, and more effective regimens that incorporate both new and repurposed agents for the treatment of TB. This narrative review provides an overview of current and emerging treatment options for drug-susceptible, drug-resistant, and latent TB based on recent clinical trials and WHO guidelines.
Details
- Title: Subtitle
- Recent advances in tuberculosis treatment: Towards shorter, safer, and more effective therapies
- Creators
- Katherine Timboe - University of IowaJ.Brooks Jackson - University of IowaGreta L. Becker - University of Iowa
- Resource Type
- Journal article
- Publication Details
- Journal of clinical tuberculosis and other mycobacterial diseases, Vol.42, 100582
- DOI
- 10.1016/j.jctube.2026.100582
- PMID
- 41624601
- PMCID
- PMC12854055
- NLM abbreviation
- J Clin Tuberc Other Mycobact Dis
- ISSN
- 2405-5794
- eISSN
- 2405-5794
- Publisher
- Elsevier Ltd
- Grant note
- Mark Gilbert and Karen Simmonds Research Gift
This work was supported by the Mark Gilbert and Karen Simmonds Research Gift.
- Language
- English
- Date published
- 2026
- Academic Unit
- Pathology
- Record Identifier
- 9985121595402771
Metrics
1 Record Views